May/June 2013

Biopharma Asia

May/June 2013 | Volume 2 Issue 3


Oral Multiparticulates as a Flexible Solid Dosage Form Approach for Paediatric Use

By: Anne Cram , Senior Principal Scientist; Jeremy A. Bartlett , Associate Research ...


Enhancing the Solubility of Poorly Soluble Drug Substances

By: Harry G. Brittain, Institute Director Center for Pharmaceutical Physics


The Global Fight Against Falsified and Substandard Medicines

By: Tom Woods, CEO Woods International LLC


An Introduction to Rapid Microbiological Methods: Regulatory Acceptance, Validation and Im...

By: Michael Miller, President of  Microbiology Consultants LLC


Considerations in the Technology Transfer and Scale up of Lyophilised Products

By: Tim McCoy, Principal Scientist; Matthew Brown, Development Scientist; Martin Addo...


Implementation of Single-Use Bioreactors for Viral Vaccines Process Development

By: Ludovic Peeters, Scientist - New Technologies; Jean-François Chaubard, Director of...


Phase III/Post-Commercialisation Changes: Extractable and Leachables Considerations for Co...

By: Ken Wong, Senior Scientist, Center for Extractables and Leachables Merck & Co.,...


Addressing Material Properties in the Design of a Direct Compression Continuous Manufactur...

By: Fernando Muzzio, Professor; Sarang Oka, Graduate; William Engisch, Graduate Rutg...